Ethics approval and consent to participate
The South African National Cause of Death Validation study was approved by the South African Medical Research Council Human Research Ethics (SAMRC) committee (EC004-2/2017). All methods were carried out in accordance with relevant guidelines and regulations as stated by the SAMRC, and according to the ethical guidelines and principles of the Department of Health: Ethics in Health Research: Principles, Processes and Structures (2015), as well as the Declaration of Helsinki (2013). The SAMRC Ethics Committee is registered as an institutional review board (IRB) with the Office for Human Research Protections (OHRP) of the United States of America Department of Health and Human Services, IRB organisation identifier: IRB00001569. The Medical Research Council's unique Assurance Number is FWA00002753, and the unique Organisation Number is IORG0001163 as well as OLAWA5726-01. In addition, further local ethics requirements, were adhered to, i.e., the Health Research Ethics Committees at provincial level for all nine provinces, as well as the district-level requirements for participating health facilities. The protocol was also reviewed in accordance with the Centers for Disease Control and Prevention (CDC) human research protection procedures. CDC investigators did not interact with human subjects, neither have access to identifiable data or specimens for research purposes, as required by the CDC. All the participants provided written informed consent to participate. Details on how informed consent was obtained have already been published (19).
Consent for publication
“Written informed consent to participate in the study and for publication of aggregate data were obtained from the next of kin of the deceased in most cases. In the remainder of cases written informed consent was obtained from an informant knowledgeable about the circumstances of death before they responded to the interview.”
Availability of data and materials
The datasets used and/or analysed during the current study are available from the corresponding author on reasonable request.
Competing interests
The authors declare that they have no competing interests.
Funding
This study has been supported in part by the President’s Emergency Plan for AIDS Relief (PEPFAR) through the Centers for Disease Control and Prevention (CDC) under the terms of Cooperative Agreement SAMRC-CDC CoAG 1U2GGH01150. The findings and conclusions in this report are those of the authors and do not necessarily represent the office position of the U.S. Centers for Disease Control and Prevention/Agency for Toxic Substances and Disease Registry. The study has also been supported by the Bloomberg Philanthropies Data for Health Initiative through the CDC Foundation Civil Registration and Vital Statistics Project, and the South African Medical Research Council. M.M. was supported by the SAMRC through its Division of Research Capacity Development under the Research Capacity Development Initiative from funding received from the South African National Treasury.
Authors’ contributions
D.B., J.J. and P.G. conceived and designed the study. D.B., P.G., M.M., N.N., O.A., C.K., T.G. prepared data for analysis. M.M., N.N., B.N. and D.B. conducted the literature review and drafted the manuscript. D.B., P.G., M.M., N.N., O.A., C.K., T.G. and Z.N. interrogated and interpreted results. All authors critically reviewed the manuscript for important intellectual content and all authors approved the final version before submission.
Acknowledgements
The fieldwork teams from GeoSpace and Epicentre are thanked for the data collection conducted across South Africa.
Professor Peter Byass is thanked for his technical advice on the InterVA for automated processing of verbal autopsy data and Ms Natashia Morris of the SAMRC Biostatistics Unit is thanked for the maps that she created for the project.
Authors' information
Burden of Disease Research Unit, South African Medical Research Council, Parow Vallei, Western Cape South Africa
Monique Maqungo,Nadine Nannan, Beatrice Nojilana, Tracy Glass, Oluwatoyin Awotiwon, Noluntu Funani, Jané Joubert, Debbie Bradshaw& Pamela Groenewald
School of Public Health and Family Medicine, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa
Debbie Bradshaw
National Center for Health Statistics, U.S. Centers for Disease Control and Prevention, Hyattsville, MD; U.S. Public Health Service. U.S. Public Health Service Commissioned Corps, Rockville, MD, USA
Erin Nichols
Associate Director of Programs KwaZulu-Natal, Division of Global HIV & TB, Centers for Disease Control and Prevention. Durban South Africa. Division of Global HIV/AIDS and TB, Centers for Disease Control and Prevention, Pretoria, South Africa
Diane Morof
Division of Global HIV/AIDS and TB, Centers for Disease Control and Prevention, Pretoria, South Africa
Mireille Cheyip
Department of Global Health, Research School of Population Health College of Health & Medicine
Chalapati Rao
Biostatistics Unit, South African Medical Research Council, Parow Vallei, Western Cape South Africa
Carl Lombard& Ria Laubscher
MRC/Wits Rural Public Health and Health Transitions Research Unit (Agincourt), School of Public Health, University of the Witwatersrand, Johannesburg, South Africa
Jessica Price, Chodziwadziwa Kabudula &Kathleen Kahn
Division of Forensic Medicine and Toxicology, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa
Lorna J. Martin
GeoSpace International, 290 Glenwood Road, Lynnwood Park, Pretoria, South Africa
Francois Bezuidenhout
Health Impact Assessment Unit, Western Cape Department of Health, Cape Town, South Africa
Nesbert Zinyakatira